secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-07-11T23:59:59+00:00
Accession:  0001104659-24-079101
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics raises $1.9M via warrant exercise inducement; issues new warrants for 3.5M shares
--------------------------------------------------------------------------------

- Gross proceeds of ~$1.9M from cash exercise of 1,762,674 existing warrants at a reduced price of $1.09 per share.
- In exchange, the company issued new inducement warrants to purchase up to 3,525,348 shares at $1.09, exercisable for 5 years from stockholder approval.
- Roth Capital Partners acted as financial advisor, receiving ~$96,000 in fees plus expense reimbursement.
- Company agreed to file a resale registration statement for the new warrant shares by July 25, 2024.
- Transaction structured as an at-market warrant inducement under Nasdaq rules; no variable rate transactions until July 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924079101/0001104659-24-079101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924079101/tm2419264d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-079101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer